← FDA Drug Approvals (Drugs@FDA)
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN LTD · Approved 2021-01-06
Drug application
- FDA Application #
ANDA213654- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
- Generic name
- Empagliflozin
- Active ingredients
- EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- LUPIN LTD
- First approval
- 2021-01-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown